| Identification | Back Directory | [Name]
3-[(2-chloro-6-fluorophenyl)methyl]-1-methyl-9-(3-methylphenyl)-7,8-dihydro-6H-purino[7,8-a]pyrimidine-2,4-dione | [CAS]
847337-63-7 | [Synonyms]
KRAS G12C inhibitor 29
3-[(2-chloro-6-fluorophenyl)methyl]-1-methyl-9-(3-methylphenyl)-7,8-dihydro-6H-purino[7,8-a]pyrimidine-2,4-dione
Pyrimido[2,1-f]purine-2,4(1H,3H)-dione, 3-[(2-chloro-6-fluorophenyl)methyl]-6,7,8,9-tetrahydro-1-methyl-9-(3-methylphenyl)- | [Molecular Formula]
C23H21ClFN5O2 | [MOL File]
847337-63-7.mol | [Molecular Weight]
453.9 |
| Hazard Information | Back Directory | [Uses]
KRAS G12C inhibitor 29 is a KRAS G12C inhibitor extracted from patent WO2021252339A1, compound 3. KRAS G12C inhibitor 29 can be used for the research of cancer[1]. | [References]
[1] Fan J, et, al. Substituted purine-2,6-dione compounds as kras inhibitors. WO2021252339A1. |
|
|